Learn about the global oncology molecular diagnostics market through The Business Research Company, which provides information on oncology molecular diagnostics market size, oncology molecular diagnostics market drivers and restraints, oncology molecular diagnostics market players, the COVID-19 impact on the oncology molecular diagnostics market, and more.

The global oncology molecular diagnostics market size is expected to grow from $3.22 billion in 2021 to $3.66 billion in 2022 at a compound annual growth rate (CAGR) of 13.6%. The global oncology molecular diagnostic market size is expected to grow to $6.34 billion in 2026 at a CAGR of 14.7%.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology molecular diagnostics market.

Request A Sample For The Global Oncology Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

The oncology molecular diagnostics market consists of sales of molecular diagnostic instruments, kits, and reagents used for diagnosing cancers and related services by entities (organizations, sole traders, and partnerships) that produce molecular diagnostic equipment for diagnosing cancer. Molecular diagnostics are tests that diagnose genetic information, proteins, or related molecules and provide health or disease information. This study is most usually performed on blood, saliva, or tumor tissue samples.

Global Oncology Molecular Diagnostics Market Segments Include:
By Product: Instruments, Reagents, Others

By Technology: Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Others

By End-User: Hospitals, Diagnostic Centres, Academic and Research Institutes, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The advanced technology in genomics is a key trend in the oncology molecular diagnostics market. Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation.

TBRC’s oncology molecular diagnostics market report covers:

Major Market Players: Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen-Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Oncology Molecular Diagnostics Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market overviews, analyzes and forecasts market size, share, oncology molecular diagnostics market players, oncology molecular diagnostics market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s oncology molecular diagnostics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Oncology Devices Global Market Report 2022

Oncology Biosimilars Global Market Report 2022

Oncology Drugs Global Market Report 2022

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: